85 related articles for article (PubMed ID: 22440655)
1. Antiangiogenic and antivascular effects of a recombinant tumstatin-derived peptide in a corneal neovascularization model.
Esipov R; Beyrakhova K; Likhvantseva V; Stepanova E; Stepanenko V; Kostromina M; Abramchik Y; Miroshnikov A
Biochimie; 2012 Jun; 94(6):1368-75. PubMed ID: 22440655
[TBL] [Abstract][Full Text] [Related]
2. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
3. NGR enhanced the anti-angiogenic activity of tum-5.
Meng J; Ma N; Yan Z; Han W; Zhang Y
J Biochem; 2006 Aug; 140(2):299-304. PubMed ID: 16845126
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification, and bioactivity of human tumstatin from Escherichia coli.
Gu Q; Zhang T; Luo J; Wang F
Protein Expr Purif; 2006 Jun; 47(2):461-6. PubMed ID: 16503164
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.
Wang Y; Yin H; Chen P; Xie L; Wang Y
Ophthalmic Res; 2011; 46(2):66-72. PubMed ID: 21242701
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis by a synthetic fusion protein VTF derived from vasostatin and tumstatin.
Gu Q; Sun C; Luo J; Zhang T; Wang L
Anticancer Drugs; 2014 Oct; 25(9):1044-51. PubMed ID: 24942148
[TBL] [Abstract][Full Text] [Related]
7. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
8. Peritumor injections of purified tumstatin delay tumor growth and lymphatic metastasis in an orthotopic oral squamous cell carcinoma model.
Chung IS; Son YI; Ko YJ; Baek CH; Cho JK; Jeong HS
Oral Oncol; 2008 Dec; 44(12):1118-26. PubMed ID: 18485794
[TBL] [Abstract][Full Text] [Related]
9. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.
Hamano Y; Kalluri R
Biochem Biophys Res Commun; 2005 Jul; 333(2):292-8. PubMed ID: 15979458
[TBL] [Abstract][Full Text] [Related]
10. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
Eikesdal HP; Sugimoto H; Birrane G; Maeshima Y; Cooke VG; Kieran M; Kalluri R
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15040-5. PubMed ID: 18818312
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant fragment of pigment epithelium-derived factor (44-77) prevents pathological corneal neovascularization].
Esipov RS; Beĭrakhova KA; Chupova LA; Likhvantseva VK; Stepanova EV; Miroshnikov AI
Bioorg Khim; 2012; 38(1):78-85. PubMed ID: 22792709
[TBL] [Abstract][Full Text] [Related]
12. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
Goto T; Ishikawa H; Matsumoto K; Nishimura D; Kusaba M; Taura N; Shibata H; Miyaaki H; Ichikawa T; Hamasaki K; Nakao K; Maeshima Y; Eguchi K
Int J Oncol; 2008 Jul; 33(1):33-40. PubMed ID: 18575748
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of recombinant anti-angiogenic peptide of tumstatin on growth and metastasis of human ovarian cancer transplanted in nude mice].
Zhang GM; Sui LH; Jia T; Zhao YZ; Fu SB; Liu XH; Yu Y
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):170-3. PubMed ID: 18756929
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of corneal angiogenesis by local application of vasostatin.
Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
[TBL] [Abstract][Full Text] [Related]
16. Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis.
Lima E Silva R; Kachi S; Akiyama H; Shen J; Aslam S; Yuan Gong Y; Khu NH; Hatara MC; Boutaud A; Peterson R; Campochiaro PA
J Cell Physiol; 2006 Jul; 208(1):161-6. PubMed ID: 16557520
[TBL] [Abstract][Full Text] [Related]
17. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
[TBL] [Abstract][Full Text] [Related]
18. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
[TBL] [Abstract][Full Text] [Related]
19. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
20. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.
Yamamoto Y; Maeshima Y; Kitayama H; Kitamura S; Takazawa Y; Sugiyama H; Yamasaki Y; Makino H
Diabetes; 2004 Jul; 53(7):1831-40. PubMed ID: 15220208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
